Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339M
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
187M
-
Shares change
-
+33.4M
-
Total reported value, excl. options
-
$429M
-
Value change
-
+$73.1M
-
Put/Call ratio
-
30.84
-
Number of buys
-
83
-
Number of sells
-
-55
-
Price
-
$2.29
Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q3 2024
173 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q3 2024.
Nuvation Bio Inc. - Common Stock (NUVB) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 187M shares
of 339M outstanding shares and own 55.17% of the company stock.
Largest 10 shareholders include FMR LLC (29.2M shares), Decheng Capital LLC (26M shares), EcoR1 Capital, LLC (19.2M shares), BlackRock, Inc. (17M shares), Omega Fund Management, LLC (13.1M shares), Octagon Capital Advisors LP (12.2M shares), VANGUARD GROUP INC (10.8M shares), STATE STREET CORP (4.17M shares), GEODE CAPITAL MANAGEMENT, LLC (4.03M shares), and TANG CAPITAL MANAGEMENT LLC (3.9M shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.